Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 proof-of-concept trial of SRK-015

Trial Profile

A Phase 2 proof-of-concept trial of SRK-015

Phase of Trial: Phase II

Latest Information Update: 06 Jun 2018

At a glance

  • Drugs SRK-015 (Primary)
  • Indications Spinal muscular atrophy
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 06 Jun 2018 New trial record
    • 31 May 2018 According to the Scholar Rock media release, the company plans to initiate this trial in the first quarter of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top